Journal of Global Infectious Diseases, published by Wolters Kluwer Medknow Publications, serves as a pivotal resource in the field of infectious diseases, offering insightful research and critical analyses that contribute to global health discourse. Since its inception as an Open Access journal in 2009, it has aimed to disseminate knowledge on various facets of infectious diseases, fostering collaboration among researchers, clinicians, and public health professionals. With an impact factor indicative of its growing significance—ranked in the Q3 category of Infectious Diseases for 2023—this journal publishes a diverse range of studies, from basic science to clinical applications. Its dedicated contributions help address pressing health challenges and enhance knowledge sharing in an era where infectious diseases pose significant threats worldwide. Based in India, the journal not only highlights regional health issues but also connects to the broader global landscape, making it an essential platform for anyone interested in advancing the field.

GERMS is a multidisciplinary journal published by the EUROPEAN ACAD HIV-AIDS & INFECTIOUS DISEASES, dedicated to advancing knowledge in the fields of epidemiology, immunology, infectious diseases, and microbiology. Since its inception in 2011, the journal has provided a crucial platform for researchers and practitioners to share innovative studies, clinical findings, and public health insights, with an eye on improving health outcomes globally. With an ISSN of 2248-2997 and a consistent publication trajectory leading up to 2024, GERMS is recognized in the third quartile across several categories, reflecting its growing impact and relevance in the scientific community. Authors and readers benefit from a range of access options, fostering the dissemination of vital research findings. As a journal situated in Romania, it also addresses regional health challenges while contributing to the broader discourse on infectious diseases and public health. GERMS is not just a repository of knowledge, but a vital resource for those engaged in combating infectious diseases and promoting health equity.

VECTOR-BORNE AND ZOONOTIC DISEASES is a prominent journal dedicated to advancing research in the fields of infectious diseases, microbiology, and virology, published by Mary Ann Liebert, Inc. With a rich history spanning from 2001 to 2024, this journal plays a critical role in disseminating cutting-edge research and insights regarding diseases transmitted by vectors and zoonotic pathogens. It has achieved notable rankings, including Q2 in the Infectious Diseases category and Q3 in both Microbiology and Virology as of 2023. The journal's emphasis on quality and relevance is further underscored by its established position—ranked 151st in Infectious Diseases and within the 43rd percentile in Virology according to Scopus. Although not an open-access journal, the publication ensures that its findings reach a broad audience of researchers, professionals, and students dedicated to tackling the challenges posed by these critical health issues. By providing a platform for innovative studies and discussions, VECTOR-BORNE AND ZOONOTIC DISEASES remains an essential resource for those at the forefront of disease research and public health strategies.

JMIR Public Health and Surveillance is a premier open access journal that has been at the forefront of public health research since its inception in 2015. Published by JMIR PUBLICATIONS, INC in Canada, this journal holds an impressive Q1 ranking in both Health Informatics and Public Health, Environmental and Occupational Health as of 2023. With a commendable Scopus Rank of #18 out of 665 in Public Health and #10 out of 138 in Health Informatics, JMIR Public Health and Surveillance stands out for its rigorous peer-reviewed articles that contribute significantly to the advancement of knowledge in these vital fields. The journal is committed to promoting research that advances the understanding and surveillance of health trends, disease outbreaks, and population health metrics, thus serving as an invaluable resource for researchers, professionals, and students alike. By facilitating open access to high-quality content, it ensures that results of critical public health research are readily available, ultimately helping to inform policy and public health initiatives across the globe.

Journal of Tropical Medicine, published by HINDAWI LTD, is a leading open-access journal dedicated to the dissemination of high-quality research within the field of tropical medicine. With an ISSN of 1687-9686 and E-ISSN 1687-9694, this journal has been providing an essential platform for researchers since 2009, facilitating a comprehensive understanding of diseases affecting tropical regions. Based in Egypt, the journal is categorized in the Q2 quartile for Medicine (miscellaneous) and Parasitology, alongside a Q3 rank in Microbiology as of 2023, highlighting its significant impact and relevance in these critical fields. The journal has earned commendable rankings within Scopus, being positioned 136th out of 636 in General Medicine, which reflects its role in advancing tropical health research. The Journal of Tropical Medicine is committed to promoting accessibility and knowledge sharing, making it an indispensable resource for professionals, researchers, and students dedicated to eradicating diseases and improving health outcomes in tropical settings.

EPIDEMIOLOGY AND INFECTION is a premier open-access journal published by Cambridge University Press, dedicated to advancing the field of epidemiology and infectious diseases. With an ISSN of 0950-2688 and E-ISSN of 1469-4409, this journal has been at the forefront of disseminating impactful research since its inception in 1970. As of 2023, it holds a prestigious Q2 ranking in both the fields of Epidemiology and Infectious Diseases, reflecting its significant contribution to these critical areas of study, with Scopus rankings placing it at #70 in Epidemiology and #163 in Infectious Diseases. The journal aims to publish high-quality, peer-reviewed studies that contribute to our understanding and management of infectious diseases globally. Operating under an open-access model since 2020, EPIDEMIOLOGY AND INFECTION ensures that research is accessible to a wide audience, fostering collaboration and innovation among researchers, professionals, and students alike. With a commitment to excellence, this journal is an essential resource for those looking to stay abreast of the latest developments in epidemiological research and infectious disease management.

Current Tropical Medicine Reports, published by Springer, is an esteemed journal that serves as a pivotal platform for researchers, professionals, and students in the fields of immunology, allergy, and infectious diseases. With a strong focus on emerging tropical medicine topics, the journal provides an authoritative avenue for disseminating innovative research and practical insights, showcasing its commitment to advancing global health knowledge. Now in its convergence years from 2014 to 2024, it has successfully established itself in the academic community, evidenced by its Q2 rankings in the categories of Infectious Diseases and Immunology and Allergy in 2023, reflecting its impact and relevance. The journal boasts impressive Scopus rankings, holding the 50th position in Infectious Diseases and 55th in Immunology and Allergy, further underscoring its significance in these critical fields. While it operates under a subscription model, the journal serves not only as a resource for published research but also as a catalyst for collaboration and knowledge exchange among the scientific community. With a growing readership, Current Tropical Medicine Reports is poised to continue shaping the discourse surrounding tropical health challenges.

Infectious Diseases and Therapy is a premier scholarly journal published by Springer London Ltd, dedicated to advancing the understanding of infectious diseases through rigorous research and evidence-based therapy. With an esteemed Q1 ranking in both the Infectious Diseases and Microbiology (medical) categories, this journal is a vital resource for researchers, healthcare professionals, and students aiming to stay at the forefront of developments within the field. Launched in 2012, it has embraced an Open Access model, ensuring that groundbreaking studies and critical reviews are accessible to a global audience. Operating from its office in London, the journal encourages the dissemination of innovative therapies and diagnostic methods, fostering collaboration and knowledge sharing among the scientific community. In a landscape where infectious diseases pose significant health challenges, Infectious Diseases and Therapy stands as an essential platform for impactful research that can lead to improved healthcare outcomes worldwide.

The Japanese Journal of Infectious Diseases, published by the National Institute of Infectious Diseases in Japan, serves as a vital platform for researchers, clinicians, and public health professionals committed to advancing the field of infectious disease science. With an ISSN of 1344-6304 and an E-ISSN of 1884-2836, this journal has maintained its academic rigor since its inception in 1961 and continues to contribute significantly to the global understanding of infectious diseases. The journal holds a Q3 ranking in the categories of Infectious Diseases, Miscellaneous Medicine, and Medical Microbiology as of 2023, reflecting its important role in disseminating impactful research. With many articles available through Open Access, it ensures wide accessibility to the latest discoveries and insights. Researchers can expect to find high-quality studies that address critical challenges in the control and prevention of infectious diseases, making this journal an essential resource for anyone engaging in this critical field.

Biosafety and Health is a leading peer-reviewed journal published by ELSEVIER, dedicated to advancing knowledge and practice in the fields of biotechnology, infectious diseases, microbiology, and public health. With an ISSN of 2096-6962 and an E-ISSN of 2590-0536, this Open Access journal has been accessible to the global research community since 2019, fostering collaboration and innovation from its base in the Netherlands. Ranked Q2 in multiple categories according to the latest metrics, including Biotechnology and Microbiology (medical), it stands as a testament to high-quality, impactful research that influences clinical and environmental practices. The journal has achieved substantial recognition in various medical fields, ranking in the 88th percentile for Public Health, Environmental and Occupational Health, and the 78th percentile for Infectious Diseases. Researchers and practitioners seeking to contribute to this evolving domain are encouraged to submit their findings, as the journal aims to promote interdisciplinary dialogue and address pressing global health challenges.